JP2017538767A5 - - Google Patents

Download PDF

Info

Publication number
JP2017538767A5
JP2017538767A5 JP2017533378A JP2017533378A JP2017538767A5 JP 2017538767 A5 JP2017538767 A5 JP 2017538767A5 JP 2017533378 A JP2017533378 A JP 2017533378A JP 2017533378 A JP2017533378 A JP 2017533378A JP 2017538767 A5 JP2017538767 A5 JP 2017538767A5
Authority
JP
Japan
Prior art keywords
use according
isoxazoline compound
formula
mammal
isoxazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533378A
Other languages
English (en)
Japanese (ja)
Other versions
JP6706262B2 (ja
JP2017538767A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/080744 external-priority patent/WO2016102437A1/en
Publication of JP2017538767A publication Critical patent/JP2017538767A/ja
Publication of JP2017538767A5 publication Critical patent/JP2017538767A5/ja
Application granted granted Critical
Publication of JP6706262B2 publication Critical patent/JP6706262B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533378A 2014-12-22 2015-12-21 毛包虫症治療のためのイソオキサゾリン化合物の使用 Active JP6706262B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14199562 2014-12-22
EP14199562.1 2014-12-22
PCT/EP2015/080744 WO2016102437A1 (en) 2014-12-22 2015-12-21 Use of isoxazoline compounds for treating demodicosis

Publications (3)

Publication Number Publication Date
JP2017538767A JP2017538767A (ja) 2017-12-28
JP2017538767A5 true JP2017538767A5 (enExample) 2019-01-24
JP6706262B2 JP6706262B2 (ja) 2020-06-03

Family

ID=52146273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017533378A Active JP6706262B2 (ja) 2014-12-22 2015-12-21 毛包虫症治療のためのイソオキサゾリン化合物の使用

Country Status (14)

Country Link
US (3) US20170348286A1 (enExample)
EP (3) EP3236960B1 (enExample)
JP (1) JP6706262B2 (enExample)
CN (2) CN106999475B (enExample)
AU (3) AU2015371175B2 (enExample)
BR (1) BR112017013286A2 (enExample)
CA (1) CA2971296A1 (enExample)
DK (2) DK4008329T3 (enExample)
ES (2) ES3037078T3 (enExample)
FI (2) FI4008329T3 (enExample)
PL (2) PL3236960T3 (enExample)
PT (2) PT4008329T (enExample)
RU (1) RU2709198C2 (enExample)
WO (1) WO2016102437A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170232024A1 (en) 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
US20170348286A1 (en) 2014-12-22 2017-12-07 Intervet Inc. Use of isoxazoline compounds for treating demodicosis
WO2018039508A1 (en) * 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CN107501199A (zh) * 2017-08-16 2017-12-22 南京农业大学 氟雷拉纳单体化合物的提取和纯化方法
MX2020006309A (es) 2017-12-15 2021-01-29 Tarsus Pharmaceuticals Inc Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.
US11880349B2 (en) 2019-04-30 2024-01-23 Salesforce, Inc. System or method to query or search a metadata driven distributed ledger or blockchain
JP7724845B2 (ja) 2020-07-24 2025-08-18 エランコ・ユーエス・インコーポレイテッド イソオキサゾリン化合物及びその中間体を作製するための方法
CN115785017B (zh) * 2022-12-06 2023-12-08 海利尔药业集团股份有限公司 一种取代的苯酰胺异噁唑啉衍生物或其作为农药可接受的盐、组合物及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067863C1 (ru) * 1994-05-25 1996-10-20 Казанский государственный технологический университет Акарицидный состав для лечения чесотки домашних животных
CN102558082B (zh) 2004-03-05 2015-09-30 日产化学工业株式会社 异噁唑啉取代苯甲酰胺化合物的制备中间体
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
MX368680B (es) 2007-06-27 2019-10-11 Du Pont Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga.
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
CA2747060A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
TWI454472B (zh) * 2008-12-19 2014-10-01 Novartis Ag 有機化合物
RU2602189C2 (ru) 2010-12-27 2016-11-10 Интервет Интернэшнл Б.В. Изоксазолиновый состав, содержащий гликофурол для наружного и местного применения
CN105616406B (zh) 2010-12-27 2019-12-13 英特维特国际股份有限公司 外用局部异噁唑啉制剂
MX2013010336A (es) 2011-03-10 2013-10-03 Zoetis Llc Derivados espirociclicos de isoxazolina como agentes antiparasitarios.
DK3172964T3 (da) * 2011-09-12 2020-11-30 Boehringer Ingelheim Animal Health Usa Inc Parasitiske sammensætninger indeholdende et isoxazolinaktivstof, fremgangsmåde og anvendelser deraf
RU2763496C2 (ru) 2012-02-06 2021-12-29 БЁРИНГЕР ИНГЕЛЬХАЙМ ЭНИМАЛ ХЕЛТ ЮЭсЭй ИНК. Паразитицидные пероральные ветеринарные композиции, включающие системно действующие активные агенты, способы и применение этих композиций и способов
CN108685894B (zh) 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品
WO2014090918A1 (en) * 2012-12-13 2014-06-19 Novartis Ag Process for the enantiomeric enrichment of diaryloxazoline derivatives
ES2971061T3 (es) * 2013-12-20 2024-06-03 Intervet Int Bv Composiciones de isoxazolina y uso de las mismas en la prevención o el tratamiento de infestaciones parasitarias en animales
US20170348286A1 (en) 2014-12-22 2017-12-07 Intervet Inc. Use of isoxazoline compounds for treating demodicosis

Similar Documents

Publication Publication Date Title
JP2017538767A5 (enExample)
JP2015512435A5 (enExample)
JP2016540809A5 (enExample)
RU2017126029A (ru) Применение изоксазолиновых соединений для лечения демодекоза
JP2013544846A5 (enExample)
JP2013510124A5 (enExample)
JP2013537203A5 (enExample)
JP2017523169A5 (enExample)
JP2016539960A5 (enExample)
JP2018517746A5 (enExample)
JP2017504635A5 (enExample)
JP2010524932A5 (enExample)
JP2016506369A5 (enExample)
JP2012144574A5 (enExample)
JP2016506962A5 (enExample)
JP2015504081A5 (enExample)
JP2014504586A5 (enExample)
JP2013545785A5 (enExample)
JP2016506960A5 (enExample)
JP2016516043A5 (enExample)
JP2013032389A5 (enExample)
JP2017508782A5 (enExample)
JP2014521688A5 (enExample)
JP2016540028A5 (enExample)
JP2017537949A5 (enExample)